CAMBRIDGE, MA / ACCESS Newswire / April 15, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live ...
FDA reversal, patent relief, and mRESVIA risks show a commoditized market and lofty $20B valuation. See more here.
Plus: Sam Altman's home has been attacked twice in two days. This is today's edition of The Download, our weekday newsletter ...
2don MSN
'Felt like I was dying': Elon Musk supports Pfizer insider who said Covid vaccine killed thousands
Sterz also cited figures from Germany’s vaccine safety monitoring system, managed by the Paul-Ehrlich-Institut, stating that ...
Despite encountering a legal roadblock last month in his effort to rework the U.S. vaccine infrastructure, HHS Secretary ...
Five vaccines in development for HIV, tuberculosis, cancer, influenza, and coronaviruses could transform global health.
That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...
US Health and Human Services Secretary Robert F. Kennedy Jr. has approved changes to rules that govern an expert group that ...
Shah Capital, which has agitated for change at the vaccine maker for years, is calling on fellow shareholders to end what it ...
Katalin Karikó, a Nobel Prize-winning scientist who pioneered mRNA research that led to life-saving vaccines during the COVID ...
CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...
An advance in vaccine technology is showing promise toward fighting the second-most common cause of death in the United States, cancer. Scientists are working on developing mRNA vaccines that would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results